HIF1α and HIF2α independently activate SRC to promote melanoma metastases
Open accessAbstract
Malignant melanoma is characterized by a propensity for early lymphatic and hematogenous spread. The hypoxia-inducible factor (HIF) family of transcription factors is upregulated in melanoma by key oncogenic drivers. HIFs promote the activation of genes involved in cancer initiation, progression, and metastases. Hypoxia has been shown to enhance the invasiveness and metastatic potential of tumor cells by regulating the genes involved in the breakdown of the ECM as well as genes that control motility and adhesion of tumor cells. Using a Pten-deficient, Braf-mutant genetically engineered mouse model of melanoma, we demonstrated that inactivation of HIF1α or HIF2α abrogates metastasis without affecting primary tumor formation. HIF1α and HIF2α drive melanoma invasion and invadopodia formation through PDGFRα and focal adhesion kinase-mediated (FAK-mediated) activation of SRC and by coordinating ECM degradation via MT1-MMP and MMP2 expression. These results establish the importance of HIFs in melanoma progression and demonstrate that HIF1α and HIF2α activate independent transcriptional programs that promote metastasis by coordinately regulating cell invasion and ECM remodeling.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Inactivation of HIF decreases the metastatic potential of tumor cells.
“whereas inactivation of HIF decreases the metastatic potential of tumor cells”
From Hypoxic control of metastasis (2016) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628 · see citing works
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945 · see citing works
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · see citing works
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · see citing works
Siegel, R. L., Ward, E., Brawley, O. W., & Jemal, A. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20121 · Cited by 4,075 · see citing works
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251 · see citing works
A tense situation: forcing tumour progression
Butcher, D. T., Alliston, T. N., & Weaver, V. M. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2544 · Cited by 1,922 · see citing works
Nanomechanical analysis of cells from cancer patients
Cross, S. E., Jin, Y., Rao, J., & Gimzewski, J. K. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.388 · Cited by 1,906 · see citing works
HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression
Keith, B., Johnson, R. S., & Simon, M. C. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3183 · Cited by 1,693 · see citing works
Self-citationDifferential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation
Hu, C.-J., Wang, L.-Y., Chodosh, L. A., Keith, B., & Simon, M. C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.24.9361-9374.2003 · Cited by 1,386 · see citing works
Self-citationDirect regulation of TWIST by HIF-1α promotes metastasis
Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345 · see citing works
BrafV600E cooperates with Pten loss to induce metastatic melanoma
Dankort, D., Curley, D. P., Cartlidge, R. A., Nelson, B., Karnezis, A. N., Damsky Jr, W. E., You, M. J., DePinho, R. A., McMahon, M., & Bosenberg, M. (2009) · Nature Genetics · doi:10.1038/ng.356 · Cited by 1,189 · see citing works
Yeatman, T. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1366 · Cited by 1,113 · see citing works
The 'ins' and 'outs' of podosomes and invadopodia: characteristics, formation and function
Murphy, D. A., & Courtneidge, S. A. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3141 · Cited by 1,057 · see citing works
Raval, R. R., Lau, K. W., Tran, M. G. B., Sowter, H. M., Mandriota, S. J., Li, J.-L., Pugh, C. W., Maxwell, P. H., Harris, A. L., & Ratcliffe, P. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5675-5686.2005 · Cited by 940 · see citing works
Role of VHL Gene Mutation in Human Cancer
Kim, W. Y., & Kaelin, W. G. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.061 · Cited by 940 · see citing works
Self-citationInhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein
Kondo, K., Klco, J., Nakamura, E., Lechpammer, M., & Kaelin, W. G. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00043-0 · Cited by 761 · see citing works
Mechanical Stiffness Grades Metastatic Potential in Patient Tumor Cells and in Cancer Cell Lines
Swaminathan, V., Mythreye, K., O’Brien, E. T., Berchuck, A., Blobe, G. C., & Superfine, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0247 · Cited by 728 · see citing works
Self-citationInhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor Growth
Kondo, K., Kim, W. Y., Lechpammer, M., & Kaelin, W. G. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000083 · Cited by 611 · see citing works
Self-citationA SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
Bertolotto, C., Lesueur, F., Giuliano, S., Strub, T., de Lichy, M., Bille, K., Dessen, P., d’Hayer, B., Mohamdi, H., Remenieras, A., et al. (2011) · Nature · doi:10.1038/nature10539 · Cited by 526 · see citing works
Twist1-Induced Invadopodia Formation Promotes Tumor Metastasis
Eckert, M. A., Lwin, T. M., Chang, A. T., Kim, J., Danis, E. P., Lucila Ohno-machado, A., & Yang, J. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.01.036 · Cited by 476 · see citing works
Lum, D. H., Kuwabara, P. E., Zarkower, D. A., & Spence, A. M. (2000) · Genes & Development · doi:10.1101/gad.853700 · Cited by 392 · see citing works
Self-citationHypoxia and Aggressive Tumor Phenotype: Implications for Therapy and Prognosis
Vaupel, P. W. (2008) · The Oncologist · doi:10.1634/theoncologist.13-s3-21 · Cited by 383 · see citing works
Hu, C.-J., Sataur, A., Wang, L., Chen, H., & Simon, M. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-05-0419 · Cited by 355 · see citing works
Self-citationFrom genes to drugs: targeted strategies for melanoma
Flaherty, K. T., Hodi, F. S., & Fisher, D. E. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3218 · Cited by 351 · see citing works
ARNT-Deficient Mice and Placental Differentiation
Kozak, K. R., Abbott, B., & Hankinson, O. (1997) · Developmental Biology · doi:10.1006/dbio.1997.8758 · Cited by 328 · see citing works
(2001) · PubMed · Cited by 270 · see citing works
Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo
Kim, W. Y., Safran, M., Buckley, M. R., Ebert, B. L., Glickman, J., Bosenberg, M., Regan, M., & Kaelin, W. G. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601300 · Cited by 235 · see citing works
Self-citationHypoxia and MITF control metastatic behaviour in mouse and human melanoma cells
Cheli, Y., Giuliano, S., Fenouille, N., Allegra, M., Hofman, V, Hofman, P., Bahadoran, P., Lacour, J.-P., Tartare-Deckert, S., Bertolotto, C., et al. (2012) · Oncogene · doi:10.1038/onc.2011.425 · Cited by 185 · see citing works
The hypoxic microenvironment of the skin contributes to Akt-mediated melanocyte transformation
Bedogni, B., Welford, S. M., Cassarino, D. S., Nickoloff, B. J., Giaccia, A. J., & Powell, M. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.11.005 · Cited by 178 · see citing works
Buscà, R., Berra, E., Gaggioli, C., Khaled, M., Bille, K., Marchetti, B., Thyss, R., Fitsialos, G., Larribère, L., Bertolotto, C., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200501067 · Cited by 178 · see citing works
Sodhi, A., Montaner, S., Miyazaki, H., & Gutkind, J. S. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5532 · Cited by 161 · see citing works
Giatromanolaki, A. N., Sivridis, E., Kouskoukis, C., Gatter, K. C., Harris, A. L., & Koukourakis, M. I. (2003) · Melanoma Research · doi:10.1097/00008390-200310000-00008 · Cited by 152 · see citing works
Mutant V600E BRAF Increases Hypoxia Inducible Factor-1α Expression in Melanoma
Kumar, S., Yu, H., Edwards, R. H., Chen, L., Kazianis, S., Brafford, P. A., Ács, G., Herlyn, M., & Xu, X. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3312 · Cited by 143 · see citing works
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
Kim, W. Y., Perera, S., Zhou, B., Carretero, J., Yeh, J. J., Heathcote, S. A., Jackson, A. L., Nikolinakos, P., Ospina, B., Naumov, G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38443 · Cited by 141 · see citing works
Self-citationRankin, E. B., Higgins, D. F., Walisser, J. A., Johnson, R. S., Bradfield, C. A., & Haase, V. H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.3163-3172.2005 · Cited by 137 · see citing works
Hypoxia-inducible Factor Regulates αvβ3 Integrin Cell Surface Expression
Dahl, K. D. C., Robertson, S. E., Weaver, V. M., & Simon, M. C. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-12-1082 · Cited by 134 · see citing works
Self-citationThe TWIST1 oncogene is a direct target of hypoxia-inducible factor-2α
Gort, E. H., van Haaften, G. W., Verlaan-Klink, I., Groot, A. J., Plasterk, R. H. A., Shvarts, A., Suijkerbuijk, K. P. M., van Laar, T., van der Wall, E., Raman, V., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210795 · Cited by 133 · see citing works
Hypoxia-induced transcriptional repression of the melanoma-associated oncogene MITF
Feige, E., Yokoyama, S., Levy, C., Khaled, M., Igras, V., Lin, R. J., Lee, S., Widlund, H. R., Granter, S. R., Kung, A. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106351108 · Cited by 119 · see citing works
Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study
Nazarian, R. M., Prieto, V. G., Elder, D. E., & Duncan, L. M. (2010) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2010.01505.x · Cited by 65 · see citing works
Self-citationHigh throughput system for magnetic manipulation of cells, polymers, and biomaterials
Spero, R. C., Vicci, L., Cribb, J., Bober, D. B., Swaminathan, V., O’Brien, E. T., Rogers, S. L., & Superfine, R. (2008) · Review of Scientific Instruments · doi:10.1063/1.2976156 · Cited by 37 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340 · see citing works
Role of Matrix Metalloproteinases in Photoaging and Photocarcinogenesis
Pittayapruek, P., Meephansan, J., Prapapan, O., Komine, M., & Ohtsuki, M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060868 · Cited by 1,099 · see citing works
Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET
Rankin, E. B., Fuh, K. C., Castellini, L., Viswanathan, K., Finger, E. C., Diep, A. N., LaGory, E. L., Kariolis, M. S., Chan, A., Lindgren, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1404848111 · Cited by 269 · see citing works
Melanocytic nevi and melanoma: unraveling a complex relationship
Damsky, W., & Bosenberg, M. (2017) · Oncogene · doi:10.1038/onc.2017.189 · Cited by 251 · see citing works
Hypoxia: Signaling the Metastatic Cascade
Rankin, E. B., Nam, J.-M., & Giaccia, A. J. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.05.006 · Cited by 240 · see citing works
Zhang, X., Li, Y., Ma, Y., Yang, L., Wang, T., Meng, X., Zong, Z., Sun, X., Hua, X., & Li, H. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0892-2 · Cited by 235 · see citing works
RetractedGenomic Analyses Reveal Potential Independent Adaptation to High Altitude in Tibetan Chickens
Wang, M., Li, Y., Peng, M., Zhong, L., Wang, Z., Li, Q., Tu, X.-L., Dong, Y., Zhu, C., Wang, L., et al. (2015) · Molecular Biology and Evolution · doi:10.1093/molbev/msv071 · Cited by 222 · see citing works
Liang, X., Chen, M., Bhattarai, P., Hameed, S., & Dai, Z. (2020) · ACS Nano · doi:10.1021/acsnano.0c05617 · Cited by 220 · see citing works
Mutation-Specific RAS Oncogenicity Explains NRAS Codon 61 Selection in Melanoma
Burd, C. E., Liu, W., Huynh, M. V., Waqas, M. A., Gillahan, J. E., Clark, K. S., Fu, K., Martin, B. L., Jeck, W. R., Souroullas, G. P., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0729 · Cited by 214 · see citing works
Pathways and therapeutic targets in melanoma
Shtivelman, E., Davies, M. A., Hwu, P., Yang, J. C.-H., Lotem, M., Oren, M., Flaherty, K. T., & Fisher, D. E. (2014) · Oncotarget · doi:10.18632/oncotarget.1892 · Cited by 219 · see citing works
Guha, M., & Avadhani, N. G. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.08.007 · Cited by 216 · see citing works
Exosomes in the hypoxic TME: from release, uptake and biofunctions to clinical applications
He, G., Peng, X., Wei, S., Yang, S., Li, X., Huang, M., Tang, S., Jin, H., Liu, J., Zhang, S., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-021-01440-5 · Cited by 201 · see citing works
Focal adhesion dynamics in cellular function and disease
Mishra, Y. G., & Manavathi, B. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110046 · Cited by 197 · see citing works
BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers
Castellani, G., Buccarelli, M., Arasi, M. B., Rossi, S., Pisanu, M. E., Bellenghi, M., Lintas, C., & Tabolacci, C. (2023) · Cancers · doi:10.3390/cancers15164026 · Cited by 188 · see citing works
Gilkes, D. M., Xiang, L., Lee, S. J., Chaturvedi, P., Hubbi, M. E., Wirtz, D., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321510111 · Cited by 184 · see citing works
RetractedHypoxia Inducible Factor Pathway and Physiological Adaptation: A Cell Survival Pathway?
Kumar, H., & Choi, D. (2015) · Mediators of Inflammation · doi:10.1155/2015/584758 · Cited by 183 · see citing works
SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis
Lamar, J. M., Xiao, Y., Norton, E., Jiang, Z.-G., Gerhard, G. M., Kooner, S., Warren, J. S. A., & Hynes, R. O. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004364 · Cited by 169 · see citing works
YAP/TAZ Activation as a Target for Treating Metastatic Cancer
Warren, J., Xiao, Y., & Lamar, J. M. (2018) · Cancers · doi:10.3390/cancers10040115 · Cited by 168 · see citing works
Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis
Ji, R. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.12.001 · Cited by 159 · see citing works
Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications
Shi, R., Liao, C., & Zhang, Q. H. (2021) · Cells · doi:10.3390/cells10030678 · Cited by 148 · see citing works
Invadosomes are coming: new insights into function and disease relevance
Paterson, E. K., & Courtneidge, S. A. (2017) · FEBS Journal · doi:10.1111/febs.14123 · Cited by 137 · see citing works
Lehmann, S., Boekhorst, V. T., Odenthal, J., Bianchi, R., van Helvert, S., Ikenberg, K., Ilina, O., Stoma, S., Xandry, J., Jiang, L., et al. (2017) · Current Biology · doi:10.1016/j.cub.2016.11.057 · Cited by 142 · see citing works
Huang, Q., Lan, F., Wang, X., Yu, Y., Ouyang, X., Zheng, F., Han, J., Lin, Y., Xie, Y., Xie, F., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-18 · Cited by 141 · see citing works
Swayampakula, M., McDonald, P. C., Vallejo, M., Coyaud, É., Chafe, S. C., Westerback, A., Venkateswaran, G., Shankar, J., Gao, G., Laurent, E. M. N., et al. (2017) · Oncogene · doi:10.1038/onc.2017.219 · Cited by 131 · see citing works
MiR-21: an environmental driver of malignant melanoma?
Melnik, B. C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0570-5 · Cited by 129 · see citing works
The potential role of HIF on tumour progression and dissemination
Unwith, S., Zhao, H., Hennah, L., & Ma, D. (2014) · International Journal of Cancer · doi:10.1002/ijc.28889 · Cited by 126 · see citing works
Laurent, V., Toulet, A., Attané, C., Milhas, D., Dauvillier, S., Zaidi, F., Clement, E., Cinato, M., Gonidec, S. L., Guérard, A., et al. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0748 · Cited by 121 · see citing works
The Different Routes to Metastasis via Hypoxia-Regulated Programs
Nobre, A. R., Entenberg, D. R., Wang, Y., Condeelis, J. S., & Aguirre‐Ghiso, J. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.06.008 · Cited by 109 · see citing works
miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α
Zhou, J., Xu, D., Xie, H., Tang, J., Liu, R., Li, J., Wang, S., Chen, X., Su, J., Zhou, X., et al. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1030545 · Cited by 97 · see citing works
The impact of hypoxia in pancreatic cancer invasion and metastasis
Díaz, B., & Yuen, A. (2014) · Hypoxia · doi:10.2147/hp.s52636 · Cited by 99 · see citing works
Rossi, A., Roberto, M., Panebianco, M., Botticelli, A., Mazzuca, F., & Marchetti, P. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172621 · Cited by 93 · see citing works
Hoffmann, C., Mao, X., Brown-Clay, J. D., Moreau, F., Absi, A. A., Wurzer, H., Sousa, B., Schmitt, F. C., Berchem, G., Janji, B., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28637-x · Cited by 92 · see citing works
Wang, J., Ding, N., Li, Y., Cheng, H., Wang, D., Yang, Q., Deng, Y., Yang, Y., 李艳鸣, 阮修艳, et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4114 · Cited by 92 · see citing works
Hypoxia-dependent drivers of melanoma progression
D’Aguanno, S., Mallone, F., Marenco, M., Bufalo, D. D., & Moramarco, A. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01926-6 · Cited by 90 · see citing works
GATA3 interacts with and stabilizes HIF-1α to enhance cancer cell invasiveness
Lin, M.-C., Lin, J., Hsu, C.-L., Juan, H., Lou, P., & Huang, M.-C. (2017) · Oncogene · doi:10.1038/onc.2017.8 · Cited by 88 · see citing works
Role of miRNAs in Melanoma Metastasis
Gajos-Michniewicz, A., & Czyż, M. (2019) · Cancers · doi:10.3390/cancers11030326 · Cited by 87 · see citing works
Hypoxia and antitumor CD8+ T cells: An incompatible alliance?
de Silly, R. V., Dietrich, P., & Walker, P. R. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1232236 · Cited by 81 · see citing works
Regulation of invadopodia by the tumor microenvironment
Gould, C. M., & Courtneidge, S. A. (2014) · Cell Adhesion & Migration · doi:10.4161/cam.28346 · Cited by 81 · see citing works
MITF controls the TCA cycle to modulate the melanoma hypoxia response
Louphrasitthiphol, P., Ledaki, I., Chauhan, J. S., Falletta, P., Siddaway, R., Buffa, F. M., Mole, D. R., Soga, T., & Goding, C. R. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12802 · Cited by 76 · see citing works
WISP-1 positively regulates angiogenesis by controlling VEGF-A expression in human osteosarcoma
Tsai, H., Tzeng, H.-E., Huang, C.-Y., Huang, Y., Tsai, C., Wang, S., Wang, P., Chang, A., Fong, Y., & Tang, C. (2017) · Cell Death and Disease · doi:10.1038/cddis.2016.421 · Cited by 76 · see citing works
Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma
Kumar, D., Gorain, M., Kundu, G., & Kundu, G. C. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0578-3 · Cited by 78 · see citing works
Rouger, J., Jakobczyk, H., Debaize, L. L., Cousin, É., Galibert, M., Troadec, M., & Gandemer, V. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.04.003 · Cited by 76 · see citing works
Asokan, S. B., Johnson, H. E., Rahman, A., King, S., Rotty, J. D., Lebedeva, I. P., Haugh, J. M., & Bear, J. E. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.10.024 · Cited by 75 · see citing works
Mitochondrial determinants of cancer health disparities
Choudhury, A. R., & Singh, K. K. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.05.001 · Cited by 74 · see citing works
Finger, E. C., Castellini, L., Rankin, E. B., Vilalta, M., Krieg, A. J., Jiang, D., Banh, A., Zundel, W., Powell, M. B., & Giaccia, A. J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1418164112 · Cited by 72 · see citing works
Carvalho, T. M. A., Molfetta, D. D., Greco, M. R., Koltai, T., Alfarouk, K. O., Reshkin, S. J., & Cardone, R. A. (2021) · Cancers · doi:10.3390/cancers13236135 · Cited by 69 · see citing works
Vascular channels formed by subpopulations of PECAM1+ melanoma cells
Dunleavey, J. M., Xiao, L., Thompson, J., Kim, M., Shields, J. M., Shelton, S. E., Irvin, D., Brings, V. E., Ollila, D. W., Brekken, R. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6200 · Cited by 69 · see citing works
Tumor Cellular and Microenvironmental Cues Controlling Invadopodia Formation
Masi, I., Caprara, V., Bagnato, A., & Rosanò, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.584181 · Cited by 64 · see citing works
de Silly, R. V., Ducimetière, L., Maroun, C. Y., Dietrich, P., Derouazi, M., & Walker, P. R. (2015) · European Journal of Immunology · doi:10.1002/eji.201445284 · Cited by 62 · see citing works
Patel, S. A., Rodrigues, P., Wesolowski, L., & Vanharanta, S. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01127-6 · Cited by 58 · see citing works
Debreova, M., Csáderová, L., Buríková, M., Lukáčiková, Ľ., Kajanová, I., Sedlakova, O., Kery, M., Kopáček, J., Zaťovičová, M., Bízik, J., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112745 · Cited by 60 · see citing works
Zhang, B.-G., Du, T., Zang, M., Chang, Q. H., Fan, Z., Li, J., Yu, B., Su, L., Li, C., Yan, C., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2513 · Cited by 58 · see citing works
RetractedWarner, A. B., & McQuade, J. L. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0814-2 · Cited by 56 · see citing works
Loftus, S. K., Baxter, L. L., Cronin, J. C., Fufa, T., Program, N. C. S., & Pavan, W. J. (2017) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12579 · Cited by 53 · see citing works
Dai, Z., Zhou, S., Zhou, Z., Bai, D.-S., Xu, X., Fu, X., Chen, Q., Zhao, Y., Zhu, K., Yu, L., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4395 · Cited by 53 · see citing works
Sakamoto, T., & Seiki, M. (2017) · Cancer Science · doi:10.1111/cas.13231 · Cited by 51 · see citing works
Miles, S. L., Fischer, A. P., Joshi, S. J., & Niles, R. M. (2015) · BMC Cancer · doi:10.1186/s12885-015-1878-5 · Cited by 51 · see citing works
HIF-1 stabilization exerts anticancer effects in breast cancer cells in vitro and in vivo
Kachamakova‐Trojanowska, N., Podkalicka, P., Bogacz, T., Barwacz, S. A., Józkowicz, A., Dulak, J., & Łoboda, A. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113922 · Cited by 48 · see citing works
Hwang, H., Baxter, L. L., Loftus, S. K., Cronin, J. C., Trivedi, N. S., Borate, B. R., & Pavan, W. J. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12255 · Cited by 47 · see citing works
Karakashev, S. V., & Reginato, M. J. (2015) · Oncotarget · doi:10.18632/oncotarget.2806 · Cited by 46 · see citing works
Mouriaux, F., Sanschagrin, F., Diorio, C., Landreville, S., Comoz, F., Petit, E., Bernaudin, M., Rousseau, A. P., Bergeron, D., & Morcos, M. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13345 · Cited by 48 · see citing works
Antony, S., Jiang, G., Wu, Y., Meitzler, J. L., Makhlouf, H. R., Haines, D. C., Butcher, D. O., Hoon, D. S. �., Ji, J. J., Zhang, Y., et al. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22708 · Cited by 44 · see citing works
Li, Y., Li, X., Kan, Q., Zhang, M., Li, X., Xu, R., Wang, J., Yu, D., Goscinski, M. A., Wen, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13717 · Cited by 41 · see citing works
Succinate dehydrogenase subunit B inhibits the AMPK-HIF-1α pathway in human ovarian cancer in vitro
Chen, L., Liu, T., Zhang, S., Zhou, J., Wang, Y., & Di, W. J. (2014) · Journal of Ovarian Research · doi:10.1186/s13048-014-0115-1 · Cited by 42 · see citing works
Mitochondrial Metabolism in Melanoma
Huang, C. Y., Radi, R., & Arbiser, J. L. (2021) · Cells · doi:10.3390/cells10113197 · Cited by 40 · see citing works
Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells
Hmada, Y. A., Brodell, R. T., Kharouf, N., Flanagan, T. W., AlAmodi, A. A., Hassan, S.-Y., Shalaby, H., Hassan, S.-L., Haïkel, Y., Megahed, M., et al. (2024) · Cancers · doi:10.3390/cancers16020470 · Cited by 40 · see citing works
The WNT ‐less wonder: WNT ‐independent β‐catenin signaling
Aktary, Z., Bertrand, J. U., & Larue, L. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12501 · Cited by 39 · see citing works
Liu, Y., Liu, Y., Yan, X., Xu, Y., Luo, F., Ye, J., Yan, H., Yang, X., Huang, X., Zhang, J., et al. (2014) · Tumor Biology · doi:10.1007/s13277-014-2056-0 · Cited by 37 · see citing works
Miao, W., Li, L., & Wang, Y. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b00986 · Cited by 37 · see citing works
TKS5-positive invadopodia-like structures in human tumor surgical specimens
Chen, Y., Baik, M. J., Byers, J. T., Chen, K. T., French, S. W., & Díaz, B. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.11.005 · Cited by 34 · see citing works
Najem, A., Soumoy, L., Sabbah, M., Krayem, M., Awada, A. H., Journé, F., & Ghanem, G. (2022) · Cells · doi:10.3390/cells11071157 · Cited by 34 · see citing works
Brain Tumor Microenvironment and Angiogenesis in Melanoma Brain Metastases
Trembath, D. G., Davis, E. S., Rao, S. G., Bradler, E., Saada, A. F., Midkiff, B. R., Snavely, A. C., Ewend, M. G., Collichio, F. A., Lee, C. B., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.604213 · Cited by 32 · see citing works
Self-citationZhang, X., Chen, Z., Zhang, T., & Wu, B. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s101872 · Cited by 32 · see citing works
Zhang, T., Lv, Q., & Jin, W. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189137 · Cited by 34 · see citing works
Effect of the PTEN gene on adhesion, invasion and metastasis of osteosarcoma cells
Hu, Y., Xu, S., Jin, W., Yi, Q., & Wei, W. (2014) · Oncology Reports · doi:10.3892/or.2014.3362 · Cited by 30 · see citing works
Zhou, W., Marinescu, M., & Veltkamp, R. C. (2014) · Neurocritical Care · doi:10.1007/s12028-014-0013-9 · Cited by 29 · see citing works
Nanomedicine as a potent strategy in melanoma tumor microenvironment
Pautu, V., Leonetti, D., Lepeltier, É., Clere, N., & Passirani, C. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.02.014 · Cited by 28 · see citing works
Bailey, K. M., Airik, M., Krook, M. A., Pedersen, E. A., & Lawlor, E. R. (2016) · Neoplasia · doi:10.1016/j.neo.2016.06.008 · Cited by 27 · see citing works
PBRM1 Inactivation Promotes Upregulation of Human Endogenous Retroviruses in a HIF-Dependent Manner
Zhou, M., Leung, J. Y., Gessner, K. H., Hepperla, A. J., Simon, J. M., Davis, I. J., & Kim, W. Y. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0480 · Cited by 27 · see citing works
Self-citationTong, S., Cinelli, M. A., El‐Sayed, N. S., Huang, H., Patel, A., Silverman, R. B., & Yang, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-05394-6 · Cited by 27 · see citing works
Martínez‐García, M. Á., Riveiro‐Falkenbach, E., Rodríguez‐Peralto, J. L., Nagore, E., Martorell, A., Campos‐Rodríguez, F., Farré, R., Blasco, L., Roca, J. B., Vives, E. C., et al. (2017) · Melanoma Research · doi:10.1097/cmr.0000000000000393 · Cited by 24 · see citing works
Inhibition of Melanoma Cell Migration and Invasion Targeting the Hypoxic Tumor Associated CAXII
Giuntini, G., Monaci, S., Cau, Y., Mori, M., Naldini, A., & Carraro, F. (2020) · Cancers · doi:10.3390/cancers12103018 · Cited by 23 · see citing works
Pucciarelli, D., Lengger, N., Takáčová, M., Csáderová, L., Bartošová, M., Breiteneder, H., Pastoreková, S., & Häfner, C. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4888 · Cited by 22 · see citing works
Caprara, V., Scappa, S., Garrafa, E., Castro, V. D., Rosanò, L., Bagnato, A., & Spinella, F. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.02.030 · Cited by 22 · see citing works
Almendros, I., Martínez‐García, M. Á., Campos‐Rodríguez, F., Riveiro‐Falkenbach, E., Rodríguez‐Peralto, J. L., Nagore, E., Martorell, A., Blasco, L., Roca, J. B., Vives, E. C., et al. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00272 · Cited by 21 · see citing works
c-Src is required for hypoxia-induced metastasis-associated functions in prostate cancer cells
Dai, Y., & Siemann, D. W. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s201320 · Cited by 21 · see citing works
Fra-2/AP-1 regulates melanoma cell metastasis by downregulating Fam212b
Chen, G., Li, R., Chen, X., Wang, J., Cao, S., Song, R., Zhao, M.-C., Li, L., Hannemann, N., Schett, G. A., et al. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-00660-4 · Cited by 21 · see citing works
Forces at play: exploring factors affecting the cancer metastasis
Riaz, F., Zhang, J., & Pan, F. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1274474 · Cited by 20 · see citing works
Rahman, S. M. T., Zhou, W., Deiters, A., & Haugh, J. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012079 · Cited by 20 · see citing works
Liu, J., Zheng, R., Zhang, Y., Jia, S., He, Y., & Liu, J. (2023) · Cancers · doi:10.3390/cancers15092640 · Cited by 19 · see citing works
Loss of Phd2 cooperates with BRAFV600E to drive melanomagenesis
Liu, S., Zhang, G., Guo, J., Chen, X., Lei, J., Ze, K., Dong, L., Dai, X., Gao, Y., Song, D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07126-9 · Cited by 19 · see citing works
Tagliatela, A. C., Hempstead, S. C., Hibshman, P. S., Hockenberry, M. A., Brighton, H. E., Pecot, C. V., & Bear, J. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-67465-w · Cited by 19 · see citing works
Lazăr, A. D., Dinescu, S., & Costache, M. (2020) · Cancers · doi:10.3390/cancers12113378 · Cited by 19 · see citing works
Hypoxia‐Inducible Factor‐1 α and CD 271 inversely correlate with melanoma invasiveness
Marconi, A., Borroni, R. G., Truzzi, F., Longo, C., Pistoni, F., Pellacani, G., & Pincelli, C. (2015) · Experimental Dermatology · doi:10.1111/exd.12679 · Cited by 19 · see citing works
Efficient inhibition of uveal melanoma via ternary siRNA complexes
Xie, L., Yang, Y., & Shen, J. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118894 · Cited by 19 · see citing works
Xu, C., Wang, X., Dai, L.-M., Chu, S., Gong, L.-L., Yang, M., & Li, Z. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-148 · Cited by 18 · see citing works
Crosstalk signaling in targeted melanoma therapy
Meierjohann, S. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9659-z · Cited by 18 · see citing works
Hypoxia-Independent Drivers of Melanoma Angiogenesis
Meierjohann, S. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00102 · Cited by 17 · see citing works
Computational models of melanoma
Albrecht, M., Lucarelli, P., Kulms, D., & Sauter, T. (2020) · Theoretical Biology and Medical Modelling · doi:10.1186/s12976-020-00126-7 · Cited by 17 · see citing works
Kyriakou, G., & Melachrinou, M. (2020) · Future Oncology · doi:10.2217/fon-2020-0151 · Cited by 17 · see citing works
- Authors
- Hanna, S. C., Krishnan, B., Bailey, S. T., Moschos, S. J., Kuan, P.-F., Shimamura, T., Osborne, L. D., Siegel, M. B., Duncan, L. M., O’Brien, E. T., Superfine, R., Miller, C. R., Simon, M. C., Wong, K.-K., & Kim, W. Y.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Loyola University Chicago (US)
- Harvard University (US)
- University of Pennsylvania (US)
- Corresponding author
- Kim, William Y.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2013-04-08
- Volume
- 123
- Issue
- 5
- Pages
- 2078-2093
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3635738
- OpenAlex
- W2085551560
- Cited by
- 147
- References
- 41
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 4 · 2022: 6 · 2021: 11 · 2020: 16 · 2019: 13 · 2018: 11 · 2017: 16 · 2016: 13 · 2015: 15 · 2014: 21 · 2013: 5
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- U.S. Department of Defense (W81XWH, W81XWH0920042)
- Damon Runyon Cancer Research Foundation
- Melanoma Research Foundation
- Melanoma Research Alliance
- National Institutes of Health (5u54ca151652-05, NIH-R01, W81XWH)
- National Cancer Institute (R01CA166480, U54‐CA151652, CA120964, CA163896, CA141576, R01CA122794, R01CA140594, CA 140594, R33CA155618, CA 122794, R01CA142794, P01CA154303, R01CA163896, P50CA093683, P01CA120964, P30CA016086, U01CA141576, CA 166480)
- National Institute of General Medical Sciences (T32GM007092)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034987)
- National Institute of Environmental Health Sciences (P30ES010126)
- Center for Gastrointestinal Biology and Disease, School of Medicine, University of North Carolina at Chapel Hill
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- HIF-1α, HIF-2α, melanoma metastasis, Src kinase, hypoxia-inducible factor, tumor invasion, invadopodia, PDGFRA, focal adhesion kinase, extracellular matrix remodeling, MT1-MMP, MMP-2, tumor cell motility
- MeSH terms
- Endothelial PAS Domain-Containing Protein 1, Animals, Hypoxia, Extracellular Matrix, Humans, Melanoma, Microscopy, Fluorescence, Mutation, Neoplasm Metastasis, Oncogenes, Skin Neoplasms, Gene Expression Regulation, Neoplastic, RNA, Small Interfering, Cell Line, Tumor, Proto-Oncogene Proteins B-raf, PTEN Phosphohydrolase, Mice, Focal Adhesion Protein-Tyrosine Kinases, Basic Helix-Loop-Helix Proteins, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
